EL

Elpiscience Biopharmaceuticals, Inc.

科望醫藥集團

Health & Medical

General Information

Official company information

Business Registration (BR) Number
76827331
Company Age
9 months
Registration Date
Registered Address
ROOM 1901, 19/F, LEE GARDEN ONE, 33 HYSAN AVENUE, CAUSEWAY BAY, HONG KONG
Date of Name Change
12 December 2024
Email
N/A
Phone
Website

Official company website with more information about products, services, and contact details.

About Elpiscience Biopharmaceuticals, Inc.

Company profile and description

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. They have pioneered a globally leading pipeline of groundbreaking immunotherapies, focusing on critical targets to address the significant unmet clinical needs in oncology and autoimmune diseases. Elpiscience's innovative approach focuses on targeting the tumor microenvironment. They also have a Bispecific Macrophage Engager Platform (BiME®) for cancer treatment.

Category

Business category and classification details

Primary Category
Health & Medical
Description
Providers of medical, dental, therapeutic, and other health-related services, including hospitals, clinics, private practices, and pharmacies.

Additional Information

Detailed company information and status

Company Type
Registered non-Hong Kong company
Location Code
HK
Company Origin
Foreign Company
Registration Status
Active
Website
https://www.elpiscience.com/
Main Contact Number
+1 215-065-1310

Company Contacts

Key contacts and leadership

Name & Position Email Contact Number Fax Number

Request For Information Free

We will attempt to gather this information through our sources

Current requests: 0

Similar Companies

Companies in the same industry or category

View All in Health & Medical

In the News

Recent media coverage and press mentions

No recent media coverage

No recent news articles found for Elpiscience Biopharmaceuticals, Inc.

Social Media

Connect with Elpiscience Biopharmaceuticals, Inc.